A Win For IMARA Inc.

Wed, Sep 07, 2022 at 07:24 PM

IMARA Inc. (IMRA:NASDAQ) rocketted at $2.01, a gain of 74.8%. On Wed, Sep 07, 2022, IMRA:NASDAQ touched a New 2-Week High of $2.01. The stock appeared on our News Catalysts scanner on Thu, Aug 25, 2022 at 07:15 AM in the 'INSIDER' category. From Wed, Aug 24, 2022, the stock recorded 66.67% Up Days and 80.00% Green Days

About IMARA Inc. (IMRA:NASDAQ)

Imara Inc is a clinical-stage biopharmaceutical company engaged in developing and commercializing novel therapeutics to treat patients suffering from rare inherited genetic disorders of haemoglobin.

Top 10 Gainers:

IMARA Inc. (IMRA:NASDAQ), 74.78%
Azure Power Global Limited (AZRE:NYSE), 35.38%
SelectQuote Inc. (SLQT:NYSE), 28.83%
Shuttle Pharmaceuticals Holdings Inc. (SHPH:NASDAQ), 27.72%
Spero Therapeutics, Inc. (SPRO:NASDAQ), 26.55%
a.k.a. Brands Holding Corp. (AKA:NYSE), 23.73%
Pingtan Marine Enterprise Ltd. (PME:NASDAQ), 23.26%
Nutex Health Inc. (NUTX:NASDAQ), 21.92%
Molecular Templates, Inc. (MTEM:NASDAQ), 21.83%
NLS Pharmaceutics Ltd. (NLSP:NASDAQ), 21.56%